MAPT and neurodegenerative disease: However, the degree of EAL defects we demonstrate in neurons upon PIKfyve inhibition would advise caution in using PIKfyve inhibitors to protect against tau or α-synuclein fibrillization and spread in neurodegenerative disease, as also discussed by Lakkaraju et al. (2021).